Mass Torts Update - Written by Beasley Allen on Thursday, February 9, 2012 8:00 - 5 Comments
The following is a requested update on the Reglan litigation in Philadelphia. Even though a state trial judge there has overruled generic drug manufacturers’ preliminary objections seeking dismissal of the claims asserted against them, the viability of the Plaintiffs’ claims are still in question and could be subject to further delay. Recently, generic drug manufacturers involved in the Philadelphia litigation jointly filed a petition for permission to appeal Judge Moss’ order to the Superior Court of Pennsylvania.
Under Pennsylvania law, the Defendants are permitted to appeal under sections 702(b) and 742 of the Pennsylvania Judicial Code when there is an order involving a controlling question of law to which there is a substantial ground for difference of opinion that an immediate appeal from the order may materially advance the ultimate determination of the matter. Here, the controlling question of law is whether, under Mensing, Plaintiffs’ claims against generic Defendants are preempted by federal law.
Many courts, including the 5th, 6th, and 8th Circuit Courts of Appeal, as well as district courts in Louisiana, Arkansas, Florida, Indiana, Georgia and New Jersey, have all dismissed state law claims raised against generic drug manufacturers. To add further support to their argument that appeal is proper under the circumstances, the generic Defendants also argue that Judge Moss’ decision was a collateral order separable from and collateral to the main cause of action, making the issue immediately appealable.
Plaintiffs who have filed suit around the country contend that Mensing may preempt failure to warn claims, but that does not imply that Mensing granted generics immunity from all tort liability. Specifically, generics are not preempted from failing to adequately communicate warnings that are consistent with information found in the labeling of its brand-name counterpart. In fact, it was alleged before the trial court in Philadelphia that no Reglan manufacturer, generic or brand, communicated the 2004 label changes, which specifically warned that drug therapy with Reglan/metoclopramide should not exceed twelve weeks, to physicians. It was this failure to communicate that led to the chronic over-prescribing of the drug and the multitude of injuries that resulted.
After Judge Moss’ ruling, the bellwether trial process reconvened in Philadelphia with the first trial set to begin in May 2012. It is unknown at this time whether the generics’ petition for appeal will disrupt the upcoming trial settings. If you need more information on this subject, contact Danielle Mason at 800-898-2034 or by email at Danielle.Mason@beasleyallen.com. Danielle has been actively involved in this litigation.
Leave a Reply
- Testosterone Multidistrict Litigation Has Been Formed
- Favorite Bible Verses
- Exploding Airbags is the Next Hidden Danger Lurking on the Horizon
- An Update on the Firm's Mass Torts Litigation
- The Travis Grant Story Is A Good One
- The Civil Justice System Does Make a Difference
- BP's Stay Request Fails Before the Supreme Court
- Favorite Bible Verses
- Eight Car Makers Join in the Recall of Exploding Airbags
- The Deepwater Horizon Claims Program is Up and Running Again
- Favorite Bible Verses
- Pollution Plagues The Water In Alabama
- New York Appeals Court Decisions May Impact Fracking Nationwide
- The Prices Of Generic Drugs Are Going Up
- John Hopkins Settles Pelvic Exam Lawsuits For $190 Million
- An Update On Boating Accidents
- There Were 10 Deaths And 123 Injured During 4th Of July Travel Period In Alabama
- Tracy Morgan Files Suit Against Wal-Mart
- OSHA Issues Safety Violations To Bridge Company
- Investigators Say Overloaded Storage Bins Caused Building Collapse
- Jury Returns $15 Million Verdict Against The Los Angeles Dodgers
- Safeguards Needed To Protect The Public Against Predatory Lenders
- It would of been nice to got a letter!!!! For my 2012 tri-glide, mine just start...
- My 2007 F150 Triton 4x4 truck has had two regulators replaced on the driver door...
- Just in case Ford ever steps up, I'm chiming in. Original Owner 2004 F150 SCrew...
- August 26, 2014 - my wife has received an August GM recall notice on her 2002 mo...
- Thanks, Tiffany Lindsay keep me posted...
- To the lawyer of this firm, something similar happen to me today while traveling...
- Ford sucks! for not recalling this issue... I am on my second replacement.
- Both my front window regulators crapped out on my 2004 f150 back in 2007. Haven...
Recent Settlements - Feb 9, 2012 7:09 - 0 Comments
More In Recent Settlements
- A Further Update On The AWP Litigation
- Firm Reaches Settlement In Fort McClellan Radio Tower Collapse Case
- Firm Reaches Settlement In Sikorsky Helicopter Crash
- The Philadelphia Story
- St. Croix, Virgin Islands Settlement
Product Liability - Aug 1, 2014 14:22 - 0 Comments
More In Product Liability
- NHTSA Finally Issues A Rear Underride Standard
- Dangers Associated With Portable Bed Handles
- A Danger in Your Home Is Hiding In Plain Sight
- Joan Claybrook Recalls Important Product Safety Issues She Dealt With As Head Of NHTSA
- GM Stops Sales Of Some Cadillacs Over Ignition Issue
Recalls Update - Aug 1, 2014 12:23 - 0 Comments
More In Recalls Update
- Unique Pharmaceuticals, Ltd. Recalls All Sterile Compounded Preparations Within Their Expire Period
- Dream On Me Recalls High Chairs Due To Strangulation And Fall Hazards
- Oeuf Recalls To Repair Cribs Due To Entrapment Hazard
- Fiberglass Boom May Conduct Electricity
- Porter-Cable Fixed-Base Production Routers Recalled Due To Electrical Shock Hazard